Stefan Kwiatkowski

This inventor holds 31 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 4 EPO patents, primarily in Heterocyclic Compounds. Top assignees: R. T. Alamo Ventures I, Inc., Srm Chemical, Ltd. Co., Alltech, Inc.. Active years: 1997-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefan Kwiatkowski. Retrieved from https://idiyas.com/inventor/stefan-kwiatkowski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 (Patent Applications = 1)

% Patents Active = 67.7

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 3)

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 22(Granted Patents)

Location History:

Richmond, KY (US) (1997 - 1998)
Lexington, KS (US) (2013)
Lexington, KY (US) (1999 - 2024)

Company Filing History:

12 out of 19

R. T. Alamo Ventures I, Inc.

patents

8 out of 10

Srm Chemical, Ltd. Co.

University of Kentucky Research Foundation

Years Active: 1997-2026

Loading Chart...

Areas of Expertise:

Vesicular Monoamine Transporter-2

Synthetic Mycotoxin Adsorbents

Selenoglycoproteins

Heterocyclic Enantiomers

Dichlorinated Compounds

Fluorinated Compounds

Carboxylated Compounds

Non-Steroidal Estrogen Receptor Ligands

Dikegulac Production

N-nitroso Compound Removal

Aromatic Amines Nitration

Pendimethalin Production

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12637410 - Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse (2026-05-26),

2. 11999676 - Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse (2024-06-04),

3. 9833486 - Compositions comprising selenium and use of same for the treatment and prevention of disease or conditions associated with mitochondrial dysfunction (2017-12-05),

4. RE45274 - Synthetic mycotoxin adsorbents and methods of making and utilizing the same (2014-12-01),

5. 8575320 - Compositions and methods for separating, characterizing and administering soluble selenoglycoproteins (2013-11-05),

6. 8426541 - Synthetic mycotoxin adsorbents and methods of making and utilizing the same (2013-04-23),

7. 8263752 - Methods for separating soluble selenoglycoproteins (2012-09-11),

8. 8153737 - Synthetic mycotoxin adsorbents and methods of making and utilizing the same (2012-04-10),

9. 7084275 - Stereospecific enrichment of heterocyclic enantiomers (2006-08-01),

10. 7045627 - Dichlorinated heterocyclic compounds and methods of synthesis (2006-05-16),

11. 7034040 - Fluorinated heterocyclic compounds and methods of synthesis (2006-04-25),

12. 6894166 - Dichlorinated heterocyclic compounds and methods of synthesis (2005-05-17),

13. 6872831 - Carboxylated heterocyclic compounds and methods of synthesis (2005-03-29),

14. 6861528 - Carboxylated heterocyclic compounds and methods of synthesis (2005-03-01),

15. 6835836 - Dichlorinated heterocyclic compounds and methods of synthesis (2004-12-28),

Title: Innovator Stefan Kwiatkowski: Pioneering Advances in Pharmaceutical Treatments

Introduction

Stefan Kwiatkowski, based in Lexington, KY, is a renowned inventor with a robust portfolio of 30 patents. His work largely focuses on innovative pharmaceutical treatments that target various diseases and disorders of the central nervous system, obesity, and metabolic dysfunctions. Kwiatkowski's contributions are significant not only in advancing medical research but also in providing new therapeutic avenues for patients in need.

Latest Patents

Kwiatkowski's recent patents include:

1. **Vesicular Monoamine Transporter-2 Ligands and Their Use in the Treatment of Psychostimulant Abuse** - This invention outlines methods for treating diseases associated with the central nervous system, eating disorders, and substance use disorders. The invention focuses on administering N-phenylalkyl amphetamine derivatives to individuals requiring treatment, demonstrating Kwiatkowski's commitment to addressing complex health issues.

2. **Compositions Comprising Selenium and Use of Same for the Treatment and Prevention of Diseases Associated with Mitochondrial Dysfunction** - This application details compositions that include selenium enriched yeast aimed at combating obesity, diabetes, and related conditions. The innovative methods highlighted in this patent suggest a therapeutic approach to enhance mitochondrial activity, underscoring the potential impact of his work on metabolic health.

Career Highlights

Throughout his career, Kwiatkowski has worked with notable institutions including R.T. Alamo Ventures I, Inc. and SRM Chemical, Ltd. Co. His tenure at these companies has allowed him to integrate cutting-edge research with practical applications, resulting in noteworthy innovations that contribute to the field of pharmaceuticals and healthcare.

Collaborations

Kwiatkowski is known for his collaborative spirit, having worked alongside esteemed colleagues such as Miroslaw Jerzy Golinski and Lowell J. Lawrence. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality and impact of his inventions.

Conclusion

Stefan Kwiatkowski stands out as a visionary inventor whose work is paving the way for new strategies in the treatment of complex health conditions. With 30 patents to his name, his innovative contributions continue to enrich the landscape of pharmaceutical science, promising better health outcomes for individuals facing challenging medical issues.

Profile summary based on public USPTO records.